Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Chimeric antigen receptor–modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whether chimeric antigen receptor T cells have clinical activity in acute lymphoblastic leukemia (ALL). Two children with relap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Grupp, Stephan A., Kalos, Michael, Barrett, David, Aplenc, Richard, Porter, David L., Rheingold, Susan R., Teachey, David T., Chew, Anne, Hauck, Bernd, Wright, J. Fraser, Milone, Michael C., Levine, Bruce L., June, Carl H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058440/
https://ncbi.nlm.nih.gov/pubmed/23527958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1215134
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados